The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

Cancer Cell 2015 Oct 1;28(4):515-528. Epub 2015 Oct 1.

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

Adenosine-to-inosine (A-to-I) RNA editing is a widespread post-transcriptional mechanism, but its genomic landscape and clinical relevance in cancer have not been investigated systematically. We characterized the global A-to-I RNA editing profiles of 6,236 patient samples of 17 cancer types from The Cancer Genome Atlas and revealed a striking diversity of altered RNA-editing patterns in tumors relative to normal tissues. We identified an appreciable number of clinically relevant editing events, many of which are in noncoding regions. We experimentally demonstrated the effects of several cross-tumor nonsynonymous RNA editing events on cell viability and provide the evidence that RNA editing could selectively affect drug sensitivity. These results highlight RNA editing as an exciting theme for investigating cancer mechanisms, biomarkers, and treatments.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108150030
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2015.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605878PMC
October 2015
30 Reads

Publication Analysis

Top Keywords

rna editing
24
a-to-i rna
12
clinical relevance
8
landscape clinical
8
editing events
8
genomic landscape
8
editing
7
rna
6
clinically relevant
4
number clinically
4
appreciable number
4
identified appreciable
4
relevant editing
4
experimentally demonstrated
4
events noncoding
4
noncoding regions
4
regions experimentally
4
tissues identified
4
rna-editing patterns
4
striking diversity
4

Similar Publications